dazucorilant   Click here for help

GtoPdb Ligand ID: 13264

Synonyms: compound 1 [PMID: 28368581] | CORT-113176 | CORT113176
Compound class: Synthetic organic
Comment: Dazucorilant (CORT-113176) is a selective glucocorticoid receptor modulator [2]. It is being explored for anti-degenerative and anti-inflammatory actions in the brain, as a mechanism to treat neurodegenerative diseases.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 0
Rotatable bonds 6
Topological polar surface area 90.79
Molecular weight 582.57
XLogP 1.56
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES C1=CC(=NC=C1)C(=O)[C@@]23CC4=C(C=C3CCN(C2)S(=O)(=O)C5=CC=C(C=C5)C(F)(F)F)N(C6=CC=C(C=C6)F)N=C4
Isomeric SMILES C1CN(C[C@@]2(C1=CC3=C(C2)C=NN3C4=CC=C(C=C4)F)C(=O)C5=CC=CC=N5)S(=O)(=O)C6=CC=C(C=C6)C(F)(F)F
InChI InChI=1S/C29H22F4N4O3S/c30-22-6-8-23(9-7-22)37-26-15-21-12-14-36(41(39,40)24-10-4-20(5-11-24)29(31,32)33)18-28(21,16-19(26)17-35-37)27(38)25-3-1-2-13-34-25/h1-11,13,15,17H,12,14,16,18H2/t28-/m0/s1
InChI Key VXOBXKQLNWYQPQ-NDEPHWFRSA-N
No information available.
Summary of Clinical Use Click here for help
Corcept Therapeutics are developing dazucorilant as a treatment for amyotrophic lateral sclerosis (ALS). The FDA designated dazucorilant as an orphan drug for ALS in August 2020.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT04249323 Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants Phase 1 Interventional Corcept Therapeutics
NCT05407324 Dazucorilant in Patients With Amyotrophic Lateral Sclerosis Phase 2 Interventional Corcept Therapeutics